Wix.com Ltd. (NASDAQ: WIX) shareholders may benefit from the website-building platform's cost-cutting measures, according to Oppenheimer.
The Analyst: Ken Wong upgraded the rating for Wix.com to Outperform, while keeping the price target unchanged at $100.
PepGen Inc (NASDAQ:PEPG) reported data from PGN-EDO51’s SAD study in adult healthy volunteers that suggest best-in-class exon skipping capabilities. SVB notes…